Chronotherapies for Parkinson's disease.
Study Goal
The researchers aimed to explore the potential of bright light therapy, physical exercise, and melatonin as chronotherapeutic tools to alleviate motor and non-motor symptoms in Parkinson's disease patients.
Results Summary
The study highlights the potential of bright light therapy, along with physical exercise and melatonin, to improve motor disorders, sleep/wake alterations, anxiety, and depression in PD patients, enhancing their quality of life. Specific recommendations are provided to optimize therapeutic benefits.
Population
Parkinson's disease patients
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
bright light | decrease | motor disorders | PD patients | - | alleviate | #1 |
bright light | decrease | sleep/wake alterations | PD patients | - | alleviate | #2 |
bright light | decrease | anxiety | PD patients | - | alleviate | #3 |
bright light | decrease | depression | PD patients | - | alleviate | #4 |
physical exercise | decrease | motor disorders | PD patients | - | alleviate | #5 |
physical exercise | decrease | sleep/wake alterations | PD patients | - | alleviate | #6 |
physical exercise | decrease | anxiety | PD patients | - | alleviate | #7 |
physical exercise | decrease | depression | PD patients | - | alleviate | #8 |
melatonin | decrease | motor disorders | PD patients | - | alleviate | #9 |
melatonin | decrease | sleep/wake alterations | PD patients | - | alleviate | #10 |
melatonin | decrease | anxiety | PD patients | - | alleviate | #11 |
melatonin | decrease | depression | PD patients | - | alleviate | #12 |
bright light | increase | general quality of life and wellbeing | PD patients | - | improve | #13 |
physical exercise | increase | general quality of life and wellbeing | PD patients | - | improve | #14 |
melatonin | increase | general quality of life and wellbeing | PD patients | - | improve | #15 |
Parkinson's disease (PD) is the second-most common progressive neurodegenerative disorder. Although the clinical diagnosis of PD is still based on its cardinal motor dysfunctions, several non-motor symptoms (NMS) have been established as integral part of the disease. Unlike motor disorders, development of therapies against NMS are still challenging and remain a critical unmet clinical need. During the last decade, several studies have characterised the molecular, physiological and behavioural alterations of the circadian system in PD patients. As a consequence, and given the ubiquitous nature of circadian rhythms in the entire organism, the biological clock has emerged as a potential therapeutic target to ease suffering from both motor and NMS in PD patients. Here we discuss the emerging field of using bright light, physical exercise and melatonin as chronotherapeutic tools to alleviate motor disorders, sleep/wake alterations, anxiety and depression in PD patients. We also highlight the potential of these readily available therapies to improve the general quality of life and wellbeing of PD patients. Finally, we provide specific data- and mechanisms-driven recommendations that might help improve the therapeutic benefit of light and physical exercise in PD patients.